34 related articles for article (PubMed ID: 18947077)
1. New prostate cancer drugs hold promise.
Cancer; 2013 Jan; 119(2):247-8. PubMed ID: 23292897
[No Abstract] [Full Text] [Related]
2. New prostate cancer drug: Prostate cancer's day in the sun.
Attard G; Reid AH; Dearnaley D; De Bono JS
BMJ; 2008 Aug; 337():a1249. PubMed ID: 18694888
[No Abstract] [Full Text] [Related]
3. Abiraterone acetate.
Logothetis CJ; Efstathiou E; Manuguid F; Kirkpatrick P
Nat Rev Drug Discov; 2011 Aug; 10(8):573-4. PubMed ID: 21804589
[No Abstract] [Full Text] [Related]
4. FDA approves prostate cancer treatment that inhibits testosterone synthesis.
Thompson CA
Am J Health Syst Pharm; 2011 Jun; 68(11):960. PubMed ID: 21593221
[No Abstract] [Full Text] [Related]
5. Prostate cancer hope.
Wallis L
Nurs Stand; 2008 Oct 8-14; 23(5):21. PubMed ID: 18947077
[TBL] [Abstract][Full Text] [Related]
6. Abiraterone acetate (Zytiga) for metastatic castration-resistant prostate cancer.
Med Lett Drugs Ther; 2011 Aug; 53(1370):63-4. PubMed ID: 21836546
[No Abstract] [Full Text] [Related]
7. [Promising on advanced cancer, several new drugs coming].
Widmark A; Karlsson CT
Lakartidningen; 2012 Feb 22-28; 109(8):416-9. PubMed ID: 22509668
[No Abstract] [Full Text] [Related]
8. Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.
Attard G; Belldegrun AS; de Bono JS
BJU Int; 2005 Dec; 96(9):1241-6. PubMed ID: 16287438
[No Abstract] [Full Text] [Related]
9. [Inhibitors of the key enzymes of androgen synthesis: potential agents as targets for prostate cancer].
Takeda M; Hosaka M
Nihon Rinsho; 2000 Jul; 58 Suppl():312-6. PubMed ID: 11022738
[No Abstract] [Full Text] [Related]
10. A new era for castrate resistant prostate cancer: a treatment review and update.
Fong MK; Hare R; Jarkowski A
J Oncol Pharm Pract; 2012 Sep; 18(3):343-54. PubMed ID: 22343966
[TBL] [Abstract][Full Text] [Related]
11. [Abiraterone acetate: a novel therapeutic option in hormone-refractory prostate cancer].
Turitto G; Di Bisceglie M; Moraca L; Sasso N; Sepede C; Suriano A; Romito S
Recenti Prog Med; 2012 Feb; 103(2):74-8. PubMed ID: 22430753
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]